ArticleBreast cancer research and treatment2026
Retrospective study of comparable survival after neoadjuvant versus adjuvant chemotherapy in cT1-2N0M0 triple-negative breast cancer.
Maxim Olsson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.